A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
One hundred and fourteen untreated patients with pathological stage (PS) IA-IIB supradiaphragmatic Hodgkin's Disease were randomised to mantle radiotherapy alone (55) or mantle radiotherapy followed by 6 courses of adjuvant chemotherapy with mustine, vinblastine, prednisolone and procarbazine-...
Main Authors: | Anderson, H., Deakin, D. P., Wagstaff, J., Jones, J. M., Todd, I. D., Wilkinson, P. M., James, R. D., Steward, W. P., Blackledge, G., Scarffe, J. H. |
---|---|
Format: | Online |
Language: | English |
Published: |
1984
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976842/ |
Similar Items
-
Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
by: Cowan, R. A., et al.
Published: (1989) -
Hodgkin's Disease
by: Scarffe, J. H.
Published: (1976) -
Derby results and practical experience of breast imaging in women following supradiaphragmatic irradiation for Hodgkin's disease
by: Turnbull, AE, et al.
Published: (2008) -
Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease
by: Antoni, Delphine, et al.
Published: (2013) -
Hodgkin's Disease and the Lymphomas, Vol. 3 (Ann. Res. Reviews)
by: Scarffe, J. H.
Published: (1980)